Hair Growth Efficacy and Safety of NGF-574H in Adult With Androgenic Alopecia

NACompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

October 2, 2018

Primary Completion Date

July 22, 2019

Study Completion Date

July 24, 2019

Conditions
Androgenic Alopecia
Interventions
OTHER

conditioned media of umbilical cord blood-derived stem cells

Hair serum with 5% conditioned media of human umbilical cord blood-derived mesenchymal stem cells

OTHER

Placebo

Hair serum without conditioned media of human umbilical cord blood-derived mesenchymal stem cells

Trial Locations (1)

31116

Dankook University Hospital, Cheonan

All Listed Sponsors
lead

Medipost Co Ltd.

INDUSTRY

NCT03676400 - Hair Growth Efficacy and Safety of NGF-574H in Adult With Androgenic Alopecia | Biotech Hunter | Biotech Hunter